MiPLA

MiPLA is a lesser-known psychedelic of the lysergamide class and a structural isomer of LSD. First discovered by Albert Hofmann during the original structure-activity research for LSD, it was later studied in greater detail by David E. Nichols at Purdue University. MiPLA is reported to produce effects similar to LSD but with a shorter duration, subtler visuals, a less introspective headspace, and a generally less anxiety-provoking profile. It is approximately two- to threefold less potent than LSD.

Also known as: Lamide, Methyl isopropyl lysergic acid

Classification

Chemical: Lysergamide
Psychoactive: Psychedelic

Effects

Pupil Dilation
Stimulation
Dilated Pupils
Nausea
Spontaneous Tactile Sensations
Euphoria
Time Distortion
Introspection
Conceptual Thinking
Analysis Enhancement
Memory Suppression
Drifting
Tracers
Color Enhancement
Visual Distortion
Pattern Recognition Enhancement

Routes of Administration

Oral

Dosage

Heavy: 300 ug
Light: 100 – 150 µg
Common: 150 – 200 µg
Strong: 200 – 250 µg
Threshold: 50 ug

Duration

Onset: 0.33-0.67 h
Comeup: 0.75-1.5 h
Peak: 1-2 h
Offset: 1-2 h

Harm Reduction

Check interactions before mixing substances, pay attention to dose spacing and hydration, and treat all dosage guidance as approximate rather than guaranteed safe.

Sources

Substance data is aggregated from the following public harm-reduction and reference sources.

Links

This static page is intended as a readable non-JS and prerender-friendly library export.

Get the full DrugsPRO experience

Open the interactive DrugsPRO app for search, saved items, interactions, and deeper harm reduction tools.

Get the PRO test kit. The simple, quick and reliable drug checking test kit. Visit https://protestkit.eu